Rare diseases
Investigational molecules
Locations
Back to Czechia39 clinical trials in Jindřichův Hradec, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
CzechiaStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
CzechiaStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
CzechiaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy
CzechiaEfficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations
CzechiaGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
CzechiaA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
CzechiaStudy of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood
CzechiaStudy on the Immune Response and Safety of a New Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months
CzechiaStudy of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Extensive studies focusing on chronic obstructive pulmonary disease (COPD) and asthma management, investigating new therapeutic approaches and treatment combinations for patients with moderate to severe conditions.
Current trials are evaluating novel medications like tezepelumab and itepekimab for improving patient outcomes.
Research focusing on vaccine development for infectious diseases, including studies on chickenpox and meningococcal vaccines for different age groups.
Clinical trials are assessing immune responses and safety profiles in children and infants.
Investigation of treatments for bronchiectasis and respiratory syncytial virus (RSV), with emphasis on developing targeted therapies for specific patient populations.
Innovative approaches are being tested to address acute and chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
